STTK SHATTUCK LABS INC
Health Care · Russell 2000
Next earnings: not announced yet
What 15 analyst firms say about SHATTUCK LABS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
15 rated views · 16 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 11 reports on STTK from 8 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 4 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Needham raised its target from $17.00 (set 8 Jun 2026) to $19.00 on 2 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Prakhar Agrawal | Buy | 27 Apr 2026 | — |
| Citigroup | Yigal Nochomovitz | Buy | 5 Jun 2026 | 7.00 USD |
| Evercore ISI | Jonathan Miller | Buy | 6 Mar 2026 | 10.00 USD |
| H.C. Wainwright | Joseph Pantginis | Buy | 1 Oct 2026 | 14.00 USD |
| Jefferies | Unnamed analyst | Buy | 5 Jun 2026 | 7.00 USD |
| JPMorgan | Brian Cheng | Buy | 24 Jul 2026 | 10.00 USD |
| Leerink Partners | Faisal Khurshid | Buy | 20 Jul 2026 | 16.00 USD |
| Leerink Partners | Will D Soghikian | Buy | 20 Jul 2026 | 16.00 USD |
| Needham | Joseph Stringer | Buy | 2 Oct 2026 | 19.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 1 Oct 2026 | 15.00 USD |
| Raymond James | Martin Auster | Buy | 24 Aug 2026 | 18.00 USD |
| TD Cowen | Stacy Ku | Buy | 24 Aug 2026 | — |
| UBS | Alice Nettleton | Buy | 11 Oct 2026 | 17.00 USD |
| Wedbush | David Nierengarten | Buy | 2 Oct 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:18 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.